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Introduction
The cap (m7GpppN) structure added co-transcriptionally to 
RNA polymerase II transcripts has been shown to influence many 
aspects of RNA metabolism, including pre-mRNA splicing,1,2 
3' end formation,3 export from the nucleus,4-6 stability7 and trans-
lation.8 In the nucleus, the cap structure interacts with the pre-
dominantly nuclear cap-binding complex (CBC), a heterodimer 
consisting of cap-binding proteins CBP20 (Mud13p in S. cerevi-
siae) and CBP80 (Sto1p or Gcr3p in S. cerevisiae).9,10 CBP20 is 
highly conserved from yeast to human, whereas CBP80 is far less 
conserved. CBP20 recognizes and binds capped RNA in conjunc-
tion with CBP80.11 CBC plays a direct role in precursor messen-
ger RNA (pre-mRNA) splicing, promoting the association of U1 
small nuclear ribonucleoprotein particle (snRNP) with the cap-
proximal 5' splice site.2,12 In Saccharomyces cerevisiae, CBC inter-
acts with Snu56p, a yeast-specific component of the U1 snRNP 
and a cbp20-∆ cbp80-∆ double mutant strain shows synthetic 
lethality with SNU71, a gene encoding for another component 
of the yeast U1 snRNP, Snu71p.13 Furthermore, CBC exits from 
the nucleus to the cytoplasm together with the mRNA,4-6 where 
it is thought to be replaced by the eIF4F complex.
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In the cytoplasm, the effect of the cap structure on mRNA 
translation is mediated by a trimeric complex termed eukaryotic 
translation initiation factor 4F, eIF4F. eIF4F consists of the cap-
binding subunit eIF4E, eIF4G and the RNA-helicase eIF4A.14 
eIF4G acts as a bridge between the cap structure and components 
of the ribosomal initiation complex.14,15 In addition to eIF4E and 
eIF4A, eIF4G interacts with the poly(A)-binding protein PABP 
(Pab1p in yeast) facilitating the functional association of the 
3' end of an mRNA with its 5' end to promote translation,16 while 
the association between eIF4G and eIF4E markedly enhances 
the binding of the latter to the cap structure.14 eIF4G and CBP80 
are both characterized by the presence of the MIF4G domain, a 
structural motif known to be present in many proteins involved 
in RNA metabolism.17,18 In S. cerevisiae there are two function-
ally redundant in translation isoforms of eIF4G, encoded by the 
genes TIF4631 and TIF4632.19
A stable association of eIF4G with CBC detected in the 
nucleus of human cells plays possibly a role in coupling RNA-
processing events in the nucleus with mRNA translation in the 
cytoplasm.20 In mammalian cells, the interaction between eIF4G 
and CBC is required for the “pioneering” round of translation 
that leads to nonsense mediated decay (NMD). NMD is a 
As evidenced from mammalian cells the eukaryotic translation initiation factor eIF4G has a putative role in nuclear RNA 
metabolism. here we investigate whether this role is conserved in the yeast Saccharomyces cerevisiae. Using a combina-
tion of in vitro and in vivo methods, we show that, similar to mammalian eIF4G, yeast eIF4G homologues, Tif4631p and 
Tif4632p, are present both in the nucleus and the cytoplasm. We show that both eIF4G proteins interact efficiently in 
vitro with UsnRNP components of the splicing machinery. More specifically, Tif4631p and Tif4632p interact efficiently 
with U1 snRNA in vitro. In addition, Tif4631p and Tif4632p associate with protein components of the splicing machinery, 
namely snu71p and Prp11p. To further delineate these interactions, we map the regions of Tif4631p and Tif4632p that are 
important for the interaction with Prp11p and snu71p and we show that addition of these regions to splicing reactions in 
vitro has a dominant inhibitory effect. The observed interactions implicate eIF4G in aspects of pre-mRNA processing. In 
support of this hypothesis, deletion of one of the eIF4G isoforms results in accumulation of un-spliced precursors for a 
number of endogenous genes, in vivo. In conclusion these observations are suggestive of the involvement of yeast eIF4G 
in pre-mRNA metabolism.
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with spliceosomal snRNPs are suggestive of a role for eIF4G in 
nuclear RNA-processing, perhaps in coupling splicing to other 
nuclear events and to translation.20
In the present work we assess the role of yeast eIF4G proteins 
in processing of RNA in the nucleus. We show the presence of 
eIF4G in the yeast nucleus and identify nuclear components that 
interact with eIF4G. We characterize in detail the interaction 
of eIF4G with protein and RNA components of the yeast spli-
ceosome. We further investigate the possible role of yeast eIF4G 
in pre-mRNA splicing in vitro, and we show that depletion of 
one of the eIF4G homologues in vivo results in accumulation 
of intron containing pre-mRNAs for a number of endogenous 
genes. Our results suggest that yeast eIF4G has a role in pre-
mRNA processing in the nucleus.
Results
Subcellular localization of Tif4631p and Tif4632p. To determine 
whether the yeast homologues of eIF4G, Tif4631p and Tif4632p, 
are present in both the cytoplasm and the nucleus, similarly to 
their human homologues, the proteins were expressed from their 
native promoter as C-terminally TAP-tagged fusion proteins 
and their localization was determined by indirect fluorescence 
and confocal microscopy. Both Tif4631p-TAP and Tif4632p-
TAP were, as expected, found to be abundant in the cytoplasm 
(Fig. 1A and B). In addition, TAP-tagged Tif4631p and to a 
lesser extent Tif4632p could be both detected also in the nucleus, 
as shown in Figure 1B, in comparison to C where the location of 
the nuclei is indicated, and in the merged image A. This finding 
prompted us to determine whether the yeast eIF4G homologues 
can interact with components of the splicing machinery, similar 
to the situation observed in human extracts.20
Interaction of Tif4631p and Tif4632p with spliceosomal 
snRNPs. Whole cell extracts were made from strains expressing 
either Tif4631p-TAP or Tif4632p-TAP and the tagged proteins 
were precipitated using protein A Sepharose. An isogenic wild 
type strain was used as a negative control. Co-precipitated RNAs 
were purified, resolved on a denaturing gel, analysed by northern 
blot analysis with oligonucleotide probes specific to U1, U2, U4, 
U5 and U6 snRNAs (Fig. 2A) and the efficiency of precipita-
tion was quantified (see legend of Fig. 2B). The eIF4G homo-
logues reproducibly pulled down U1 snRNA. More specifically, 
~20% of the input levels of U1 snRNA were pulled down by 
Tif4631p-TAP, whereas ~6% was precipitated by Tif4632-TAP 
(Fig. 2A and B), while more than 60% of the input U1 snRNA 
levels were precipitated under the same conditions by the TAP-
tagged yeast CBP20 homologue, Mud13p (data not shown). The 
interaction of Tif4631p with U1 snRNA was reduced to ~10% of 
the input levels in increased salt concentration, whereas the less 
efficient interaction of this particular UsnRNA with Tif4632p 
could withstand salt much better, remaining at similar levels at 
350 mM NaCl (Fig. 2A and B). Furthermore, ~7% of the input 
levels of U6 snRNA and ~10% of U4 snRNA were also pulled 
down by both eIF4G homologues, however these amounts were 
significantly reduced by increased salt concentration, mainly for 
Tif4631p and to a lesser extent for Tif4632p (Fig. 2B). Finally, 
surveillance mechanism comprising the recognition and subse-
quent degradation of mRNAs bearing a premature termination 
codon.21 Research in human cell lines suggests that both nuclear 
and cytoplasmic NMD occur on CBC-associated rather than 
eIF4E-associated mRNA, suggesting a role for CBC in transla-
tion.22,23 In mammalian cells, NMD is translation and splicing 
dependent.24-27 Ferraiulo et al.28 reported that translation initia-
tion factor eIF4AIII, a mammalian nucleo-cytoplasmic shuttling 
protein that interacts physically or functionally with eIF4G, is 
loaded onto the mRNA during splicing in the nucleus and then 
functions during NMD, indicating one more link between 
nuclear and cytoplasmic RNA processing events.
In Saccharomyces cerevisiae the domain of eIF4G responsible 
for the interaction with CBC resides between the eIF4E binding 
motif and the MIF4G domain.29 Fortes et al.29 proposed a role for 
the CBC-eIF4G interaction in the exchange of CBC for eIF4E 
and/or the direct recruitment of nascent mRNA for translation. 
However, it is not known whether this interaction occurs in the 
cytoplasm or in the nucleus. The latter can not be excluded since 
CBC as well as many components of the translation machinery 
are present in both cellular compartments.4,30-32 In S. cerevisiae 
the interaction between eIF4G and CBC is not required for the 
first round of mRNA translation that proceeds NMD, while the 
exact role of this interaction is yet to be defined.33 Yeast two-
hybrid experiments have previously suggested that S. cerevi-
siae splicing factors, such as Prp11p and Snu71p could interact 
with the yeast eIF4G protein,34 and the interaction of Prp11p 
with Tif4631p was proposed by Ho et al.35 in a high through-
put mass spectrometric protein complex identification screen. 
In human cells, association of eIF4G with pre-mRNA and the 
spliceosome, as well as partial co-localization of nuclear eIF4G 
Figure 1. Yeast eIF4G homologues are distributed between the 
nucleus and the cytoplasm. Wild-type yeast cells (control) and cells 
expressing TIF4631:TAP or TIF4632:TAP were grown to OD600: 0.2–0.4 
and immobilized on slides as described in Materials and Methods. The 
location of Tif4631p and Tif4632p was detected with rabbit IgG Alexa 
488 labeled (B). DAPI staining was used for the localization of the nuclei 
(c). The merged image is also presented in (A).
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a specific association between Prp11p and Tif4631p, character-
ized by the presence of two pools of complexes, since a great per-
centage of the interaction was lost at increased salt concentration 
less than 5% of the input levels of U5 
and U2 snRNAs were precipitated 
by the eIF4G homologues, and these 
interactions were greatly abolished 
when salt was increased to 350 mM 
NaCl (Fig. 2B). There was no sig-
nificant precipitation of UsnRNAs 
from whole cell extracts prepared 
from the isogenic wild type strain 
(Fig. 2A, lanes 2 and 3) indicating 
that the detected RNAs were pulled 
down via their interaction with 
Tif4631-TAP and Tif4632-TAP pro-
teins. These results suggest a specific 
interaction of both Tif4631p and 
Tif4632p mainly with U1 snRNA, 
with the interaction of Tif4631p and 
U1snRNA being more prominent 
(Fig. 2). In addition, both proteins 
can pull down to a similar extent U4 
and U6 snRNAs (Fig. 2B).
Interaction of Tif4631p and 
Tif4632p with protein components 
of U1 and U2 snRNPs. There is evi-
dence from yeast 2-hybrid screens 
that Tif4631p can interact specifi-
cally with the U2 snRNP protein, 
Prp11p and the U1 snRNP specific 
protein Snu71p, whereas Tif4632p 
was found to interact with Prp11p.34 
To assess these interactions GST-
Prp11p and GST-Snu71p fusion pro-
teins were expressed in E. coli and 
bound to Glutathione-Sepharose 
beads. The immobilized proteins 
were incubated with 35S-labeled 
Tif4631p or Tif4632p and the puri-
fied complexes were analysed by 
SDS-PAGE and fluorography. Both 
Tif4631p and Tif4632p were pulled 
down by the immobilized GST-
Prp11p very efficiently (Fig. 3A, 
lanes 1 and 2). Both proteins were 
also pulled down by GST-Snu71p, 
although in substantially lower 
amounts than with GST-Prp11p 
(Fig. 3A, lanes 7 and 8), whereas no 
protein was bound to Glutathione-
Sepharose beads alone (lanes 4–6), 
indicating that the observed binding 
was specific. Incubation of the immo-
bilized GST-Prp11p with 35S labelled 
Snu71p and analysis of the purified 
complexes gave no detectable signal (Fig. 3A, lane 3), showing 
that the interaction detected between Tif4631p, Tif4632p and 
GST-Prp11p and -Snu71p is specific. We propose that there is 
Figure 2. Yeast eIF4G homologues can precipitate U1 and U2 snRNA in vitro. (A) Yeast extracts 
derived from strains expressing either Tif4631p-TAP (lanes 4–6) or Tif4632p-TAP (lanes 7–9), as well 
as the isogenic wild-type strain (lanes 1–3), were incubated with IgG-sepharose beads under increas-
ing salt concentration (lanes 2, 5, 8: 150 mM Nacl, lanes 3, 6, 9: 350 mM Nacl). The co-precipitated 
RNAs, as well as 20% of the input RNAs (lanes 1, 4, 7), were assayed by northern blotting, using specific 
oligonucleotide-probes for each of the U1, U2, U4, U5 and U6 snRNAs. (B) Densitometry and Phospho-
rimager analysis were both used to quantify the signal produced by the northern analysis presented in 
(A), using the TotaLab software (Nonlinear Dynamics, UK) and ImageQuant software respectively. The 
results presented are means ± seM from three independent experiments.
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whereas deletions extending beyond amino 
acid 567 resulted in loss of interaction with 
 GST-Snu71p (Fig. 4A). The above suggest 
that the minimal region of Tif4631p required 
for interaction with Prp11p resides between 
residues 494 and 529 (Fig. 4A).
To define in further detail the minimal 
domain of Tif4631p required for interac-
tion with Prp11p, 10aa deletion mutants of 
Tif4631p were expressed and assayed in pull 
down assays with GST-Prp11p as described 
above. Figure 4B shows that individual dele-
tion of aa 491–501, 534–544 or 566–576 
reduced significantly the amount of Tif4631p 
mutant that could be pulled down by GST-
Prp11p (lanes 2–4, compared to lane 1), 
suggesting that these residues contribute to 
the interaction between these proteins. It is 
noteworthy that none of these deletions was 
enough to abolish the interaction completely. 
In addition, substitution of residues 496–
498 or 506–508 with Ala residues showed 
that these specific amino acids, and more 
crucially residues 506–508 are important 
for the interaction of Tif4631p with GST-
Prp11p (Fig. 4B, lanes 6, 7 compared to lane 
1). On the other hand, deletion of residues 
457–467, 469–479 (Fig. 4C, lane 5 and data 
not shown), as well as 565–647 (Fig. 4C) 
did not affect significantly the levels of Tif4631p mutant that 
could be pulled down by GST-Prp11p, as expected (Fig. 4A). 
Taken together these findings suggest that the absolutely essen-
tial region of Tif4631p required for the interaction with Prp11p 
resides between amino acids 508–529. It is obvious, however, 
that all amino acids within the region of 494–529 contribute to 
the high affinity interaction of Tif4631p with Prp11p, since dele-
tion of individual domains within this region, in the context of 
an otherwise full-length protein do not abolish the interaction 
completely. The fact that a Tif4631p mutant lacking aa 504 to 
952 can not be pulled down by GST-Prp11p (Fig. 4C) and nei-
ther can be a mutant lacking residues 1–529 (Fig. 4A), verifies 
that residues 504–529 are absolutely required for the interaction 
of Tif4631p with GST-Prp11p in our pull down assays. Using the 
same approach we mapped the region of Tif4631p interacting 
with Snu71p between amino acids 567 and 647 (Fig. 4A) and 
that was verified by the finding that deletion of residues 565–647 
of Tif4631p resulted in loss of the interaction of this protein with 
GST-Snu71p in our pull-down assays (Fig. 4D, lane 4).
Fortes et al.29 found that amino acids 490–592 are required 
for the interaction of Tif4631p with yeast CBC. The fact that 
this region includes also the residues necessary for interaction 
with Prp11p and Snu71p, as described above, prompted us to 
investigate whether we could characterize in more detail the 
individual interactions of this domain. Using our Tif4631p trun-
cated and deletion mutants we found that deletion of amino acids 
491–501 resulted in more than 30% reduction of the interaction 
(up to 500 mM NaCl, Fig. 3B, lanes 1–3) while a small but 
significant percentage was persistent even at very high salt con-
centration. The interaction of Tif4631p with Snu71p was less 
resistant to the highest salt concentration used (Fig. 3B, lanes 
6–8). RNase A treatment did not significantly alter the bind-
ing pattern, demonstrating that the interaction of Tif4631p and 
Tif4632p with both Prp11p and Snu71p is not RNA mediated 
(Fig. 3B, lanes 9–11, and data not shown).
Mapping of the domain of Tif4631p that interacts with 
splicing factors. To map the domains of Tif4631p that are 
responsible for the interactions with both Snu71p and Prp11p, 
N-terminal and C-terminal truncated forms of Tif4631p were 
generated, in vitro translated and used in GST pull down experi-
ments using immobilized GST-Prp11p or GST-Snu71p (Fig. 4A). 
Deletion of residues 657–952 from the C-terminus of Tif4631p 
had no effect on binding efficiency of this protein to either 
GST-Prp11p or GST-Snu71p. Further deletion of amino acids 
593–656 resulted in about 30% less efficient binding, whereas 
complete loss of pull-down efficiency was evidenced when amino 
acids 267–592 were also deleted (Fig. 4A). In addition, delet-
ing the N-terminal residues up to amino acid 452 did not affect 
the binding efficiency of Tif4631p for either Prp11p or Snu71p 
(Fig. 4A). Further deletion of amino acids 453–493 resulted in 
approximately 50% reduction of the interaction efficiency with 
Prp11p, while still maintaining the interaction with Snu71p 
(Fig. 4A). After sequential deletion of amino acids 494–528 the 
truncated Tif4631p could not be pulled down by GST-Prp11p, 
Figure 3. Yeast eIF4G homologues interact with protein components of U1 and U2 snRNPs. 
(A) Immobilized GsT-Prp11p (lanes 1–3) or GsT-snu71p (lanes 7 and 8) were incubated with 
35s-labeled Tif4631p, Tif4632p or snu71p as described in Materials and Methods. The pulled-
down proteins were resolved by sDs-PAGe, and visualized by autoradiography. GsT alone 
immobilized on Glutathione-sepharose beads was used as negative control (lanes 4–6). 1/20 of 
input 35s-labeled proteins were also analysed (lanes 9–11). (B) Immobilized GsT-Prp11p (lanes 
1–3, 10 and 11) or GsT-snu71p (lanes 6–8) or GsT alone (lanes 4 and 5) were incubated with 
35s-labeled Tif4631p, in the presence of increasing amounts of Nacl, or in the presence (+) or 
absence (-) of 200 ng/ml RNase A as indicated. The pulled-down proteins were resolved by 
sDs-PAGe, and visualized by autoradiography. 1/10 of the input 35s-labeled proteins were also 
analysed (lane 9).
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Figure 4. For figure legend, see page 568.
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increasing amounts of these conserved domains fused to GST 
at their N-terminus. Addition of either GST-Tif4631p(453-647) 
(Fig. 5A, lanes 3–5) or GST-Tif4632p(424-609) (lanes 6–8) 
resulted in inhibition of splicing, as judged by the production 
of less intermediate (intron-3' exon) and final (intron-lariat) 
products of splicing, compared to the control (Fig. 5A, lane 2). 
Addition of GST alone had a minor effect in the efficiency of the 
splicing reaction (Fig. 5A, lanes 9–11). Consequently, addition 
of increasing amounts of either the Tif4631p or the Tif4632p 
domains in the splicing reaction resulted in an increasing inhibi-
tory effect (Fig. 5B). Addition of the GST-Tif4631p mutant lack-
ing amino acids 534–544, and therefore unable to interact with 
yeast CBP20, in in vitro splicing reaction showed that this domi-
nant negative effect could not be attributed to selective sequestra-
tion of CBC by Tif4631p (data not shown). The above findings 
suggest that inhibition of splicing caused by Tif4631p(453-647) 
and Tif4632p(424-609) is possibly due to sequestration of spli-
ceosomal components like Prp11p and Snu71p away from the 
spliceosomal machinery.
Deletion of TIF4631 results in accumulation of certain pre-
mRNAs in vivo. The interaction of Tif4631p and Tif4632p with 
components of U1 and U2 snRNPs, together with the ability of 
Tif4631p(453-647) and Tif4632p(424-609) domains to inhibit 
splicing in vitro, suggested a possible role for the yeast eIF4G 
homologues in splicing. To test this hypothesis, given that double 
deletion of the yeast eIF4G homologues is lethal,19 we assayed 
splicing in vitro using extract prepared from a strain deleted 
of TIF4631, and expressing TAP-tagged Tif4632p that could 
sequentially be depleted by IgG-Sepharose beads. Analysis of the 
RNA products of splicing showed no significant difference in the 
levels of splicing between control and TIF4631 deleted/Tif4632p 
depleted extracts, indicating that Tif4631p or Tif4632p could 
not be made limiting for efficient splicing in vitro. Western blot 
analysis performed to check the depletion level of Tif4632p in the 
extracts showed that we could not completely deplete Tif4632p. 
Consequently, we can not completely exclude the possibility that 
Tif4631p and Tif4632p play a role in splicing, since we possi-
bly could not reduce yeast eIF4G homologues to limiting levels 
for splicing in vitro. We therefore focused our attention on splic-
ing in vivo by assaying the splicing efficiency of different pre-
mRNAs globally in the wild type and tif4631-∆ strains using 
efficiency with TAP-Mud13p (Fig. 4E, lanes 4 and 5) and we 
identified the minimal region of Tif4631p required for interac-
tion with TAP-tagged yeast CBP20 (Mud13p) in vitro to reside 
between residues 522 and 612 (data not shown). In addition, 
we identified a Tif4631p deletion mutant lacking amino acids 
534–544, that could still bind to GST-Prp11p, but had abolished 
completely the interaction with TAP-Mud13p (Fig. 4E, lanes 3 
and 6). This finding indicates that residues 534–544 of Tif4631p 
are essential for the interaction with yeast CBC. More impor-
tantly, the fact that Tif4631p-∆(534-544) interacts with Prp11p 
but not with Mud13p shows that Tif4631p can interact with 
Prp11p in a CBC-independent manner. A summary of the above 
described domains, as well as a schematic representation of the 
domains of Tif4631p that are known to be required for interac-
tion with Pabp1p36 and eIF4E,37 as well as the MIF4G domain17 
are shown for comparison in Figure 4E.
Sequence comparison shows that the region of Tif4631p that 
interacts with Prp11p, Snu71p and Mud13p is also very highly 
conserved in Tif4632p.19 Using the same method as for Tif4631p, 
N-terminal and C-terminal truncation mutants of Tif4632p were 
assayed for their efficiency to bind to Prp11p and Snu71p and 
amino acids 424–609 were defined as the minimum region of 
Tif4632p required for interaction with Prp11p and Snu71p (data 
not shown).
Inhibition of splicing in vitro by Tif4631p/Tif4632p 
interaction domains. As shown in Figure 3C, the binding of 
Tif4631
494-952
 to Prp11p was noticeably less than that observed 
with Tif4631
453-952
. To obtain the minimum domain of Tif4631p 
that interacts efficiently with U1 and U2 snRNP proteins we 
constructed a Tif4631p domain mutant spanning amino acids 
453 to 647, so as to include the region of Tif4631p that interacts 
with Snu71p. We refer to this construct as “Tif4631p(453-647)”. 
Similarly, a construct with the Tif4632p domain required for 
interaction with both Prp11p and Snu71p was made and we refer 
to this construct as “Tif4632p(424-609)”. After verifying, by 
pull-down experiments with GST-Prp11p and GST-Snu71 pro-
teins, that domains Tif4631p(453-647) and Tif4632p(424-609) 
interact specifically with both Prp11p and Snu71p in vitro (data 
not shown), we used these constructs to determine whether 
Tif4631p(453-647) and Tif4632p(424-609) can influence 
splicing by supplementing in vitro splicing reactions with 
Figure 4. Detailed mapping of the interaction of Tif4631p with snu71p and Prp11p. (A) schematic representation of the deletion mutants of Tif4631p. 
Pull-down experiments were performed by incubation of immobilized GsT-Pp11p or GsT-snu71p with 35s-labeled full-length or truncated Tif4631p 
mutants and analysed as described in Figure 3A. Densitometry was used to quantify the respective autoradiographs and the quantification results are 
presented as % percentages of the input protein used for the pull-down experiments. (B) Immobilized GsT-Prp11p (lanes 1–7) was incubated with 
35s-labeled Tif4631p (wt) or the Tif4632p-mutant proteins indicated, as described in Figure 3. The pulled-down proteins were resolved by sDs-PAGe, 
and visualized by autoradiography. 1/5 of input 35s-labeled proteins were also analysed (lanes 8–15). (c) Immobilized GsT-Prp11p (lanes 4–6) was 
incubated with 35s-labeled Tif4631p (wt) or the Tif4632p mutants indicated. The pulled-down proteins were resolved by sDs-PAGe, and visualized by 
autoradiography. GsT alone immobilized on Glutathione-sepharose beads was used as negative control (lanes 7–9). 1/5 of input 35s-labeled proteins 
were also analysed (lanes 1–3). The full length 35s-labeled proteins are indicated by arrows. (D) Immobilized GsT-snu71p (lanes 4–6) were incubated 
with 35s-labeled Tif4631p (wt) or the Tif4632p mutants indicated. The pulled-down proteins were resolved by sDs-PAGe, and visualized by autoradiog-
raphy. GsT alone immobilized on Glutathione-sepharose beads was used as negative control (lanes 7–9). 1/5 of input 35s-labeled proteins were also 
analysed (lanes 1–3). The full length 35s-labeled proteins are indicated by arrows. (e) Immobilized GsT-Prp11p (lanes 1–3) or TAP-Mud13p (lanes 4–6) 
were incubated with 35s-labeled wild-type Tif4631p (wt) or Tif4631p mutants lacking amino acid residues 491–501 (∆491-501), or 534–544 (∆534-544). 
The pulled-down proteins were resolved by sDs-PAGe and visualized by autoradiography. 1/5 of the input 35s-labeled proteins was also analysed for 
comparison. (F) schematic representation of the domain of Tif4631p required for interaction with Prp11p, snu71p and cBc. Other characterized 
domains of Tif4631p are also indicated (see text for details).
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promotes association of U1 snRNA with the cap proximal 
5' splice site.2,12
Consistent with these results, we provide evidence here for 
the interaction of yeast eIF4G homologues with spliceosomal 
UsnRNPs. We show that mainly Tif4631p, and Tif4632p to 
a lesser extent, interact with U1 snRNA. In addition, both 
eIF4G homologues are also shown to interact stably with the 
U1 snRNP component Snu71p, either directly or via other 
proteins present in the reticulocyte lysate used in our assays. 
This particular interaction, however, is much less efficient pos-
sibly because Snu71p alone does not mediate the interaction 
of eIF4G proteins with U1 snRNP. Using pull-down binding 
assays, we show that both eIF4G homologues interact very effi-
ciently and stably with Prp11p, a U2 snRNP component in an 
RNA-independent manner, whereas our TAP-tagged eIF4G 
homologues can only pull down a minor amount of U2 snRNA 
in vitro. This finding suggests that the high affinity interaction 
of yeast eIF4G proteins with Prp11p is independent of its inter-
action with U2 snRNA. The finding that eIF4G homologues 
can pull down U4 and U6 snRNAs to a similar extent is not 
unexpected since the existence of a penta-snRNP complex has 
been proposed for yeast.41
splicing microarrays.38 Total RNA was extracted from the above 
strains and hybridized to slides containing an array of oligonu-
cleotides able to hybridize to all the intron-containing RNAs of 
S. cerevisiae and to distinguish between pre-mRNAs and 
mRNAs.38 These oligonucleotides were complementary to the 
5' exon-intron junction of each one of the S. cerevisiae pre-
mRNAs, or to the intron itself or to the exon-exon junction of 
each one of the mature mRNAs (Fig. 6A). For data normaliza-
tion purposes oligonucleotides able to hybridize to the 3' exon of 
each one of all the pre-mRNAs and mRNAs were also used.
Out of 257 genes tested, there were 6 that consistently, in five 
independent experiments, showed accumulation of pre-mRNA 
at least two-fold or more in the tif4631-∆ strain compared to the 
isogenic control strain (Table 2). Similar analysis performed for a 
tif4632-∆ strain did not show any significant change in the pre-
mRNA or mRNA levels, compared to the isogenic control strain. 
The microarray results were then verified for the gene YJR145C, 
for which accumulation of pre-mRNA could be detected in the 
tif4631-∆ strain compared to the wt strain, using primer exten-
sion experiments (Fig. 6B, lanes 1 and 2; quantified in C). As 
a positive control we used the prp2-1 strain, that is deficient in 
splicing and exhibits a much stronger splicing block at the non-
permissive temperature (37°C)14 (Figs. 6B, lanes 3 and 4 and 
5C). YJR145C is the systematic name used for the gene RPS4A, 
which gives rise to the ribosomal protein Rps4Ap, a protein 
identical to Rps4Bp. The primer used for the primer extension 
experiment could hybridize to pre-mRNA and mRNA entities 
representing both genes. A two- to three-fold accumulation of 
the pre-mRNAs corresponding to both RPS4A and RPS4B could 
be detected in the tif46321-∆ strain compared to the isogenic 
control strain, whereas strain prp2-1 showed the expected strong 
splicing deficient phenotype (Fig. 6C).
Discussion
In the present study, we investigate the putative role of the yeast 
translation initiation factor eIF4G in nuclear pre-mRNA pro-
cessing. Using in situ localization we show that, in addition to 
their expected cytoplasmic localization, eIF4G homologues of 
S. cerevisiae, Tif4631p and to a smaller extent Tif4632p, exhibit 
a significant presence in the yeast nucleus. This agrees with pre-
vious reports that have demonstrated the presence of eIF4G in 
the nucleus of HeLa cells, indicative of a possible role for eIF4G 
in nuclear RNA processing.20,39 Huh et al.40 however, report 
that both yeast eIF4G homologues are located in the cytoplasm, 
using C-terminally GFP-tagged fusion constructs, fluorescent 
microscopy and an experimental approach different to ours.
In the cytoplasm, eIF4G plays an essential role in translation 
by acting as an adapter molecule during the initiation phase 
of protein synthesis. Within its sequence it contains domains 
that interact with eIF4E, eIF4A, eIF3, PABP and Mnk1.14 In 
addition, S. cerevisiae eIF4G has been shown to interact with 
the cap binding complex, CBC, via a domain between eIF4E 
and eIF3 binding sites.29 McKendrick et al.20 have shown that, 
in mammalian cells, a nuclear pool of eIF4G is closely associ-
ated with CBC. Moreover, it is known that CBC in the nucleus 
Figure 5. Tif4631p(453-647) and Tif4632p(424-609) inhibit splicing in 
vitro. (A) Increasing amounts (0.2–1 μg) of a GsT-Tif4631p(453-647) 
(lanes 3–5) or GsT-Tif4632p(424-609) (lanes 6–8) or GsT alone (lanes 
9–11), were added to in vitro splicing reactions, and the RNA products 
were analyzed by denaturing gel electrophoresis and autoradiography. 
Lane 1 shows the pre-mRNA used and lane 2 shows the control reac-
tion without the addition of any protein. (B) histogram derived from 
the quantification of data presented in (A) by phosphorimager analysis. 
Both spliced products (lariat and lariat exon) were quantified and are 
represented as a percentage of the unspliced pre-mRNA.
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sequestering them away from the 
splicing machinery, supporting the 
hypothesis that eIF4G proteins can 
participate in pre-mRNA processing 
events.
To further investigate the possible 
role of yeast eIF4G in splicing, we 
undertook a global analysis of pre-
mRNA splicing using microarrays. 
A subset of six pre-mRNAs showed a 
reproducible two- to three-fold accu-
mulation of pre-mRNAs in strains 
deleted of the TIF4631 compared to 
the isogenic control (Table 2). Even 
though the possibility of this being an 
indirect effect can not be ruled out, 
it is interesting that the same result 
was not observed when this microar-
ray analysis was applied on a strain 
deleted of the TIF4632, where no 
accumulation of any pre-mRNA was observed. Our results show 
that predominantly Tif4631p interacts with spliceosomal U1 
snRNP in vitro, and this interaction could be possibly required 
for efficient processing of certain pre-mRNAs. Analysis and com-
parison of intron sequences and splice sites of the pre-mRNAs 
presented in Table 2 did not reveal any obvious common features 
between these RNAs, apart from the fact that they are all pre-
mRNAs that will give rise to ribosomal proteins. In addition, 
Fine mapping of the individual domains of eIF4G proteins 
required for the interaction with Prp11p, CBC and Snu71p shows 
that they are distinct, but adjacent to each other and together 
they form an “interaction domain” that resides in a region that 
is highly conserved between the two yeast eIF4G isoforms. 
Addition of a recombinant form of the above defined “interac-
tion domain” of yeast eIF4G can efficiently inhibit splicing in 
vitro, possibly by interacting with spliceosomal components and 
Figure 6. Accumulation of pre-
mRNAs in tif4631-∆ strain in vivo. (A) 
schematic overview of the splicing 
microarray. Four different probes able 
to detect intermediate species of the 
two stages of splicing were designed 
and used on the microarray. The intron 
probe (black), as well as the 5'-exon-
intron probe (dark grey) can only be 
hybridized to by un-spliced RNA. The 
mature junction probe (grey) will only 
be hybridized to by processed mRNA, 
whereas the exon 2 probe (white) will 
be hybridized to by both pre-mRNA 
and mRNA and is used as a control to 
remove effects due to differential gene 
expression. (B) Total RNA was ex-
tracted from the tif4631-∆ strain as well 
as from the isogenic wild-type and was 
used in primer extension experiment, 
as described in Materials and Methods. 
The cDNAs were analysed by denatur-
ing gel electrophoresis and autoradiog-
raphy. RNA from strain prp2-1, grown 
either at 23°c or at 37°c was also used 
in the same experiment as a control. 
The positions of both the mature and 
precursor mRNAs for both RPS4A and 
RPS4B are indicated. (C) Quantification 
of the bands corresponding to both 
pre-mRNAs and mRNAs of the gel 
presented in (B) by phosphorimaging.
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5'-GGA TCC TAA TAC GAC TCA CTA TAG GAA CAG 
ACC ACC ATG ACA CCA ATT GAA GAT GTC-3' for amino 
acids 422–952, 5'-GGA TCC TAA TAC GAC TCA CTA TAG 
GAA CAG ACC ACC ATG GGT CCT GAT ATC AAA TAC for 
amino acids 438–952, 5'-GGA TCC TAA TAC GAC TCA CTA 
TAG GAA CAG ACC ACC ATG CCA ACT TTC TTG CTT 
C-3' for amino acids 453–952, 5'-GGA TCC TAA TAC GAC 
TCA CTA TAG GAA CAG ACC ACC ATG GGA GAT TCT 
GGC AGA TTC GGC-3' for amino acids 494–952, 5'-GGA 
TCC TAA TAC GAC TCA CTA TAG GAA CAG ACC ACC 
ATG AGA AGA TCA AAG AGA-3' for amino acids 529–952, 
5'-GGA TCC TAA TAC GAC TCA CTA TAG GAA CAG ACC 
ACC ATG AAG GAA GAA GTT GCT CC-3' for amino acids 
567–952, 5'-GGA TCC TAA TAC GAC TCA CTA TAG GAA 
CAG ACC ACC ATG GAC GGA AAG ACC GAC TAT TGG-
3' for amino acids 596–952, 5'-GGA TCC TAA TAC GAC TCA 
CTA TAG GAA CAG ACC ACC ATG GCT ATT GCA AAC 
ATA TCA G-3' for amino acids 631–952, 5'-GGA TCC TAA 
TAC GAC TCA CTA TAG GAA CAG ACC ACC ATG GCT 
GTG ATA GAA CAG-3' for amino acids 647–952. The PCR 
products were purified and used directly in in vitro transcription/
translation reactions with rabbit reticulocyte lysates according to 
manufacturer’s instructions (Promega) to obtain the 35S-labeled 
truncated versions of Tif4631p.
To construct deletion mutant Tif4631p-∆(565-647), the PCR 
product produced by forward primer 5'-TAT ACA TAT GGC 
CCA ACT TTC-3' and reverse primer 5'-CGA CGA TAT CGT 
CCT CTC TTT TC-3' on pBS-Tif4631 as a template, was 
digested with NdeI/EcoRV and the PCR product produced by 
forward primer 5'-CAC CGA TAT CGA ACA GAT TTT C-3' 
and reverse primer 5'-CGC AGG ATC CAA GAG AAT GAA 
TGA C-3' was digested with EcoRV/SacII. The digested PCR 
products were ligated with each other and the pBS-Tif4631 frag-
ment derived from NdeI/SacII digest. For construction of pBS-
Tif4631-∆(504-952), pBS-Tif4631 was digested with MscI/StuI 
and the respective fragment was gel extracted and ligated.
The strains of S. cerevisiae used in this study are described in 
Table 1. Standard yeast growth conditions and manipulations 
were used.
In situ localization. Yeast strains TIF4631::TAP or 
TIF463::TAP were grown to OD
600
 = 0.2–0.4 and paraformal-
dehyde (EMS) was added to final concentration 4%. Cells were 
harvested, washed in buffer B (1.2 M sorbitol, 65 mM KH
2
PO
4
, 
35 mM K
2
HPO
4
) at 4°C and resuspended in 1 ml of buffer B. 
five of these RNAs are characterized by the presence of a non-
consensus 5' splice site. The interaction of eIF4G with UsnRNPs 
during splicing in vivo could be possibly necessary as a check 
point during the processing of these pre-mRNAs. In support 
of this, a partial but significant co-localization of eIF4G with a 
proportion of snRNPs at discrete foci was reported in mamma-
lian cells,20 a finding that strengthens the hypothesis that eIF4G 
might participate in the processing of some pre-mRNAs in the 
nucleus.
In conclusion, we present here a detailed mapping of the 
domains of yeast eIF4G required for interaction with compo-
nents of the spliceosomal machinery. These interactions probably 
implicate eIF4G in nuclear RNA processing events in S. cerevisiae. 
Even though yeast eIF4G interacts specifically with spliceosomal 
components, it is not required for splicing of the RNAs tested in 
vitro, but a small but significant accumulation of pre-mRNAs is 
observed in a tif4631-∆ strain in vivo. A tif4632-∆ strain does not 
exhibit the same effect, a finding that might explain the normal 
growth phenotype of this strain, in contrast to the slow growth 
phenotype of tif4631-∆ strain reported by Goyer et al.19 At present 
we can not explain why the genetic depletion of one of the eIF4G 
homologues in yeast affects the splicing of a small number of pre-
mRNAs that correspond to ribosomal proteins. There is evidence 
of an auto-regulatory role for alternative splicing coupled NMD 
in the expression of a number of ribosomal proteins,42-44 while 
MIF4G,17 a domain that is conserved between eIF4G, Upf2p/
NMD2p and CBP80 implicates eIF4G and CBP80 in nonsense-
mediated decay. One could suggest that eIF4G participates in 
nuclear RNA processing by linking in some way pre-mRNA 
splicing with degradation pathways like NMD and acting once 
more as a scaffold protein that brings important protein compo-
nents together.
Materials and Methods
Plasmids and S. cerevisiae strains. Plasmids pBS-Tif4631 and 
pBS-Tif4632 were used as templates for coupled in vitro transcrip-
tion-translation reactions in rabbit reticulocyte lysates to express 
[35S]-labeled eIF4G proteins. They were constructed by sub-
cloning PCR amplified TIF4631 and TIF4632 genomic DNAs 
respectively into pBS(SK-) (Stratagene) as EcoR1/BamH1 frag-
ments with primers 5'-GGG AAT TCA TGA CAG ACG AAA 
CTG TCA AC-3' and 5'-CCG GAT CCT TAC TCT TCG TCA 
TCA CTT TCT-3' for TIF4631 and 5'-GGG AAT TCA TGA 
CTG ACC AAA GAG GTC CAC-3' and 5'-CCG GAT CCT 
TAA TCA CTG TCC CCA TCG TTA-3' for TIF4632. Plasmid 
pGEX4T-1-Prp11 was used to express GST-Prp11p. The ORF of 
PRP11 was subcloned as a Sal1/SmaI fragment from pAS2DD-
prp11,34 into pGEX4T-1 XhoI/SmaI restriction sites. To produce 
plasmids expressing C-terminally truncated versions of Tif4631, 
pBS-TIF4631 was digested with each of BstBI, StuI, NheI and BlpI 
to obtain the 1–765, 1–656, 1–592 and 1–266 truncated forms of 
Tif4631p respectively. To obtain N-terminally truncated versions, 
a reverse primer 5'-CTT ACT CTT CGT CAT CAC TTT CTC 
CC-3' and the following forward primers were used to amplify by 
PCR the fragments of TIF4631 referred next to each primer:
Table 1. S. cerevisiae strains used in this study
Name Genotype
TIF4631::TAP MATa ade2-101 his3-∆200 leu2-∆1 trp1-∆99 ura3-∆ 99 
cir0tif4631-TAP::TRP1
TIF4632::TAP MATa ade2-101 his3-∆200 leu2-∆1 trp1-∆99 ura3-∆ 99 
cir0tif4632-TAP::TRP1
tif4631-∆ MATalpha ade2 his3 leu2 trp1 ura3(GAL+) tif4631∆::HIS3
tif4632-∆ MATalpha ade2 his3 leu2 trp1 ura3(GAL+) tif4632∆::HIS3
tif4631-∆; 
TIF4632::TAP
MATa ade2-101 his3-∆200 leu2-∆1 trp1-∆99 ura3-∆ 99 
cir0tif4632-TAP::TRP1 tif4631∆::HIS3
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OD
600
 = 2 and cells were harvested and lysed in buffer A (10 mM 
HEPES pH 7.9, 10 mM KCl, 1.5 mM MgCl
2
, 0.5 mM DTT, 
0.5 mM PMSF, 1 μM leupeptin, 2 μM pepstatin A, 4 μM chy-
mostatin, 2.6 μM aprotinin) by French press. The TAP-tagged 
proteins were purified by incubating the yeast cell lysates with 50 
μl of a 50% solution of IgG Sepharose beads for 2.5 hrs at 4°C. 
To analyse the RNAs that are pulled down by Tif4631-TAP or 
Tif4632-TAP proteins, the beads were washed extensively with 
either IPP150 buffer (150 mM NaCl, 0.1% Nonidet P-40, 10 mM 
Tris, pH 8.0) or IPP350 buffer (350 mM NaCl, 0.1% Nonidet 
P-40, 10 mM Tris, pH 8.0) and then the RNA was extracted 
by phenol/chloroform, precipitated and analysed on a 6% acryl-
amide gel. Northern hybridization followed using the following 
specific oligonucleotide probes: 5'-CTT AAG GTA AGT AT-3' 
for U1, 5'-CTA CAC TTG ATC TAA GCC AAA AGG C-3' for 
U2, 5'-AAT ATG GCA AGC CC-3' for U5, 5'-CTC TTT GTA 
AAA CGG TTC-3' for U6 and 5'-CCG TGC ATA AGG AT-3' 
for U4snRNA.
Preparation of whole cell extracts of yeast. The protocol 
of Umen and Guthrie45 was used with minor modifications. 
Namely, the yeast strain of interest was grown to OD
600
 = 0.5–1 
at 30°C in 1L YPD medium. Cells were harvested by centrifuga-
tion at 5,000 rpm for 5 min (Beckman JLA10.500 rotor) and 
washed twice with 20 ml of AGK buffer (10 mM HEPES pH 
7.9, 1.5 mM MgCl
2
, 200 mM KCl, 10% Glycerol, 2 mM DTT). 
Cells were resuspended in 0.4 cell pellet volume of AGK buffer 
and squirted through a syringe into liquid nitrogen. The frozen 
cell pellet was ground to a fine powder by mortar and pestle and 
allowed to thaw. The thawed powder was centrifuged at 17,000 
rpm for 30 min at 2°C (rotor JA25.50 Beckman). The superna-
tant was centrifuged at 40,000 rpm for 1 hr at 4°C (rotor 70.1Ti, 
Beckman) and subsequently dialysed for 3 hrs against buffer D 
(20 mM HEPES pH 7.0, 50 mM KCl, 0.2 mM EDTA, 20% 
(v/v) glycerol) at 4°C, centrifuged at 13,000 rpm for 10 min and 
frozen at -80°C.
In vitro splicing. In vitro splicing reactions were carried out 
and analysed as described by Lin et al.46 Actin pre-mRNA was 
transcribed from linearized by BamHI plasmid p283,47 which 
contains an AluI fragment of the yeast actin gene cloned at a 
SmaI site of pGEM vector.
Microarrays. Total RNA was prepared as described by 
Schmitt et al.48 while the microarrays used were similar to those 
described by Clark et al.49 More precisely, there were at least four 
After incubation with 1 mg oxalyticase for 10 min at 30°C, cells 
were washed with ice-cold buffer B and resuspended in 0.65 ml 
of the same buffer. A 0.1 ml aliquot was put on to a coverslip, 
allowed to stand for 30 min and then washed with 3 ml of buffer 
B, replaced with 5 ml of methanol and left for 5 min at -20°C. 
After a final wash with buffer B, cells were permeabilized by buffer 
C (0.1% Triton X-100, 20 mM HEPES pH 7.9, 200 mM NaCl) 
for 30 min. Primary antibody (Rabbit IgG Alexa 488 labelled, 
Molecular Probes) was used in 1:100 dilution in buffer C, for 1 
hr. Washes with buffer C followed and after briefly rinsing with 
PBS the coverslip was mounted with vectashield with DAPI and 
examined using a Leica confocal microscope with three lasers 
giving excitation lines at 380, 488 and 543 nm. The data from 
the channels were collected separately using narrow-bandpass 
filter settings. In multiple staining experiments, the laser intensi-
ties and data collection settings were adjusted to avoid overlap 
(bleedthrough) between channels. The coupled microscope was 
a Leica DMIBRE equipped with a 633 water immersion objective 
lens (numerical aperture, 1.4). Data sets were processed using 
the Leica TCS NT, version 1.4.338, software package and were 
subsequently exported into Adobe Photoshop version 5.5, and 
Deneba Canvas version 7.02.
In vitro pull down. For purification of GST fusion proteins, 
Escherichia coli extracts from BL21-codon plus cells expressing 
either GST-Prp11p or GST-Snu71p fusion proteins were prepared 
by inducing 1 liter culture of exponentially growing cells at OD
600
 
of 0.6–0.8, for 3.5 hrs with 1 mM IPTG. Cells were harvested, 
resuspended in PBS with 0.5% Triton X-100 and lysed by French 
press. The lysate was incubated with 500 μl of Glutathione-
Sepharose beads for 2 hrs at 4°C. The beads were washed exten-
sively with PBS-0.5% Triton X-100 and used subsequently in 
the binding assays. For in vitro transcription/translation reac-
tions of TIF4631 or TIF4632, the TNT® system (Promega) and 
plasmids pBS-TIF4631 or pBS-TIF4632 were used according to 
manufacturer’s instructions. For binding assays, GST-fusion pro-
teins bound to glutathione-sepharose beads were incubated with 
Tif4631p or Tif4632p produced with the TNT® system and the 
reaction mixtures were incubated for 2 hrs at 4°C. After extensive 
washing with PBS-0.5% Triton X-100, the proteins were eluted by 
SDS sample buffer and analysed by SDS/PAGE. For the detection 
of 35S proteins, the EA starter kit was used (Thistle Scientific).
Purification of Tif4631p-TAP, Tif4632p-TAP proteins. 
Yeast strains TIF4631::TAP and TIF4632::TAP were grown to 
Table 2. Genes showing a splicing deficiency in the yeast strain tif4631-∆, their respective ORFs and the ratio of pre-mRNA in the tif4631-∆ strain 
compared to the wt strain
Gene ORF tif4631-∆/wt Exon 1 5' splice site Branch point 3' splice site Intron size
YBR181c RPs6B 2.06 gaag guaugua uuuacuaacaa guauuauuuauaacag 352
YOR096W RPs7A 2.07 agaa guauguu cuuacuaacat uuuccuucuuuuauag 401
YGL189c RPs26A 2.22 agua guauguu guuacuaacua augaauauuuaauuag 368
YLR448W RPL6B 2.33 acaa guaugug uauacuaacua gauaugucaauuauag 384
YhR203c RPs4B 2.89 gacc guauguu uuuacuaacaa acgauuuuucauauag 269
YJR145c RPs4A 3.16 gacc guauguu uuuacuaacga auuuuuuuccguacag 256
sequences of the 5' splice site, the branch point and the 3' splice sites, as well as the size of the corresponding introns are shown (according to Lopez 
et al.51).
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10–16 hrs in a humid chamber. Then the arrays were washed in 
1x SSC, 0.2% SDS followed by 0.1x SSC, 0.2% SDS and finally 
0.1x SSC, all at room temperature for 5 minutes. Scanning was 
performed in an Affymetrix 418 scanner and spot quantitation 
was carried out by ImageQuant v3.1.
To normalize, the background corrected intensity value for 
each spot was divided by the background corrected intensity value 
from the corresponding 3'exon probe. More precisely, in a mutant 
strain where the pre-mRNA of a specific gene is more than the 
respective mRNA, one would see more RNA hybridized to the 
oligonucleotides that complement the 5'exon-intron junction or/
and intron rather than the one complementary to the exon-exon 
junction, when compared to the wt strain. The above signals 
were compared to each other after normalization by the signal 
the specific RNA gives with the oligonucleotide that hybridizes 
to each 3' exon and recognizes it in both pre- and mature forms. 
Additionally, the signal that this RNA gives on the position of 
the 3'exon recognizing oligonucleotide probe should be equal to 
the sum of the signal it gives with the 5'exon-intron recognizing 
oligonucleotide probe, plus the signal from the hybridization with 
the exon-exon junction recognizing oligonucleotide probe. On 
the other hand, the same amount of RNA is expected to hybrid-
ize to the oligonucleotide probe that complements the 3' exon 
of this RNA for both control and mutant strain, since the total 
amount of the specific RNA should be equal in both strains.
For the primer extension experiments performed to check 
the microarray results, total RNA prepared as described above 
was hybridized with a 32P-labeled oligonucleotide probe with the 
sequence 5'-AGA AAG ACA ATC AAT GGC AAG GA-3' that 
hybridizes in exon 2 of the YJR145C pre-mRNA. The reverse 
transcription reaction was performed as described by Bousquet-
Antonelli et al.50
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oligonucleotide probes per S. cerevisiae transcript, containing an 
intron, immobilized on to the microarray. One probe was com-
plementary to the 5'exon-intron junction of all the pre-mRNAs, 
one probe was complementary to sequences of the intron, another 
probe was complementary to the exon-exon junction of all the 
mature mRNAs and finally there was also a probe that would 
hybridize to the 3' exon of all the pre-mRNAs and mRNAs used 
for normalization. For transcripts containing more than one 
intron and/or different predictions of intron start and end points, 
the 5' and mature exon-exon junction probes (and occasionally 
the intron probe) were duplicated as necessary to identify all pos-
sible introns. These probes were synthesized by MWG-Biotech 
AG and have an average length of 41.2 nucleotides. Ideally a probe 
should have a Tm of 80–90°C (nearest neighbor algorithm), 
where constraints of the target sequence would allow. Similarly 
all the probes to a transcript were designed to have a Tm within 
±2°C of each other where possible. These probes were printed in 
triplicate on to poly-lysine slides (Sigma) in 3x SSC buffer at the 
GTI (Chancellor’s Building, Royal Infirmary, Edinburgh) using 
a GMS 417 (Affymetrix) printer. This microarray was hybridized 
with Cy dye labeled cDNA derived from total RNA from the 
mutant strain of interest and an isogenic wild type. The reverse 
transcription reaction was performed in the presence of Cy dye 
modified dUTP (Amersham). Either Cy3 or Cy5 was used to 
label the mutant and the other to label the wild type cDNA, 
including at least one occasion where the dyes were swapped from 
their normal total RNA type (dye flip labeling). Thermoscript 
(Invitrogen) was used to perform the reverse transcription reac-
tion at 47°C using the manufacturer’s supplied buffers and 
20–50 μg of total RNA. Priming was from gene specific primers 
designed to bind downstream to the 3' exon probe (45 μM total 
concentration). The RNA was removed using 55 mM NaOH, 28 
mM EDTA pH 8 and 65°C for 30 minutes before neutralization 
with 120 mM Tris pH 7.5 at 4°C. The labeled cDNAs (mutant 
and wild type), were combined and spun in YM-100 columns 
(Millipore), using the manufacturer’s instructions, in 10 mM 
Tris pH 7.5 (used to wash twice more) to filter-purify and con-
centrate. The arrays were blocked with 1-methyl-2-pyrrolidinone 
(93% v/v) and succinic anhydride (1.64% w/v) in 68.5 mM boric 
acid (pH 7 with NaOH) at room temperature for 20 minutes 
and then pre-hybridized by 5x SSC, 0.1% (w/v) SDS, 1% (w/v) 
BSA at 47°C for 45 minutes before hybridization. The hybridiza-
tion solution was 5x SSC, 0.4% (w/v) SDS and 20 μg of human 
COT-1 DNA in 16 μl under a 22 x 22 mm coverslip at 47°C for 
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